Analysis of free carnitine in plasma of ESRD patients undergoing chronic dialysis: What is the best assay?

Dialysis and Transplantation

Volumn 32, Issue 6, 2003, Pages

  Fornasini, GianFranco ^a   Evans, Allan M ^b  

^a Sigma Tau Pharmaceuticals Inc   (United States)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLCARNITINE; CARNITINE;

ANALYTIC METHOD; ASSAY; CALIBRATION; DIALYSIS; ENZYME ASSAY; EXTRACTION; FILTER; HEALTH CARE POLICY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTERMETHOD COMPARISON; KIDNEY FAILURE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN DETERMINATION; PROTEIN HYDROLYSIS; QUALITY CONTROL; RADIOIMMUNOASSAY; REIMBURSEMENT; REVIEW; SPECTROPHOTOMETRY; VALIDATION PROCESS;

EID: 0037637472     PISSN: 00902934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (69)

1. Fritz IB, Schulz SK, Srere PA. Properties of partially purified carnitine acetyl transferase. J Biol Chem 1963; 238:2509-2517.
2. Marquis N, Fritz I. Enzymological determination of free carnitine excretions in rat tissues. J Lipid Res 1964; 5:184-187.
3. Cederblad G, Lindstedt S. Excretion of L-carnitine in man. Clin Chim Acta 1971; 33:117-123.
4. Wieland OH, Deufel T, Paetzke-Brunner I. Free carnitine and esterified carnitine-colorimetric method. In: Methods of Enzymatic Analysis, Bergmeyer HU (ed.). 1985; 8:481-488
5. Maehara M, Kinoshita S, Watanabe K. A simple fluorometric method for the determination of serum free carnitine. Clin Chim Acta 1988; 171:311-316.
6. Deufel T. Determination of L-carnitine in biological fluids and tissues. Int Clin Chem Clin Biochem 1990; 28:307-311.
7. Pearson DJ, Tubbs PK. A sensitive enzymatic assay for carnitine. Biochem J 1964; 91:2C-4C.
8. Pearson DJ, Tubbs PK, Chase JFA. Carnitine and acetylcarnitines. In: Methods of Enzymatic Analysis, Bergmeyer M (ed.). New York, NY: Academic Press, 1974:1758-1771.
9. Seccombe DW, Dodek P, Frohlich J, Hahn P, Skala JP, Campbell DJ. Automated method for L-carnitine determination. Clin Chem 1976; 22(10):1589-1592.
10. Cederblad G, Harper P, Lindgren K. Spectrophotometry of carnitine in biological fluids and tissue with a Cobas Bio centrifugal analyzer. Clin Chem 1986; 32:342-346.
11. Roe DS, Terada N, Millington DS. Automated analysis for free and short-chain acylcarnitine in plasma with a centrifugal analyzer. Clin Chem 1992; 38:2215-2220.
12. Cederblad G, Lindstedt S. A method for the determination of carnitine in the picomole range. Clin Chim Acta 1972; 37:235-243.
13. Bohmer T, Rydning A, Solberg HE. Carnitine levels in human serum in health and disease. Clin Chim Acta 1974; 57:55-61.
14. McGarry JD, Foster DW. An improved and simplified radio-isotopic assay for the determination of free and esterified carnitine. J Lipid Res 1976; 17:277-281.
15. Parvin R, Pande S. Microdetermination of (-)carnitine and carnitine acetyltransferase activity. Anal Biochem 1977; 79:190-201.
16. De Sousa C, English NR, Stacey TE, Chalmers RA. Measurement of L-carnitine and acylcarnitines in body fluids and tissues in children and in adults. Clin Chim Acta 1990; 187:317-328.
17. Christiansen RZ, Bremer J. Acetylation of tris(hydroxymethyl)aminomethane (Tris) and Tris derivatives by carnitine acetyl-transferase. FEBS letters 1978; 86(1):99-101.
18. Fishlock RC, Bieber LL, Snoswell AM. Sources of error in determinations of carnitine and acylcarnitine in plasma. Clin Chem 1984; 30:316-318.
19. Marzo A, Cardace G, Corbelletta C, Verga P, Vinciguerra C. Interference of heparin in plasma levocarnitine determination with radioenzyme assay. Arzneimittelforschung 1995; 45:1303-1305.
20. Pande SV, Caramancion MN. A simple radioisotopic assay of acetylcarnitine and acetyl-CoA at picomolar levels. Anal Biochem 1981; 112:30-38.
21. Pande SV. Radioisotopic assay of acetylcarnitine and acetyl-CoA. Methods Enzymol 1986; 123:259-263.
22. Kerner J, Bieber LL. A radioisotopic-exchange method for quantification of short-chain (acid-soluble) acylcarnitines. Anal Biochem 1983; 134:459-466.
23. Bieber LL, Kerner J. Short-chain acylcarnitines: Identification and quantitation. Methods Enzymol 1986; 123:264-276.
24. Schmidt-Sommerfeld E, Penn D, Duran M, Bennett MJ, Santer R, Stanley CA. Detection of inborn errors of fatty acid oxidation from acylcarnitine analysis of plasma and blood spots with the radioisotopic exchange-high-performance liquid chromatographic method. J Pediatr 1993; 122:708-714.
25. Schmidt-Sommerfeld E, Zhang L, Bobrowski PJ, Penn D. Quantitation of short- and medium-chain acylcarnitines in plasma by radioisotopic exchange/high-performance liquid chromatography. Anal Biochem 1995; 231:27-33.
26. Hoppel CL, Brass EP, Gibbons AP, Turkaly JS. Separation of acylcarnitines from biological samples using high-performance liquid chromatography. Anal Biochem 1986; 156:111-117.
27. Matsumoto K, Takahashi M, Takiyama N, et al. Enzyme reactor for urinary acylcarnitines assay by reversed-phase high-performance liquid chromatography. Clin Chim Acta 1993; 216:135-143.
28. Minkler PE, Ingalls ST, Hoppel CL. High-performance liquid chromatographic separation of acylcarnitines following derivatization with 4'-bromophenacyl trifluoromethanesulfonate. Anal Biochem 1990; 185:29-35.
29. Van Kempen TATG, Odle J. Quantification of carnitine esters by high-performance liquid chromatography. Effect of feeding medium-chain triglycerides on plasma carnitine ester profile. J Chromatogr 1992; 584:157-165.
30. Bhuiyan AK, Jackson S, Turnbull DM, Aynsley-Green A, Leonard JV, Bartlett K. The measurement of carnitine and acylcarnitines: Application to the investigation of patients with suspected inherited disorders of mitochondrial fatty acid oxidation. Clin Chim Acta 1992; 207:185-204.
31. Kamimori H, Hamashima Y, Konishi M. Determination of carnitine and saturated-acyl group carnitines in human urine by high-performance liquid chromatography with fluorescence detection. Anal Biochem 1994; 218:417-424.
32. Minkler PE, Brass EP, Hiatt WR, Ingalls ST, Hoppel CL. Quantification of carnitine, acetylcarnitine, and total carnitine in tissues by high-performance liquid chromatography: The effect of exercise on carnitine homeostasis in man. Anal Biochem 1995; 231:315-322.
33. Kuroda N, Ohyama Y, Nakashima K, Akiyama S. HPLC determination of carnitine and acylcarnitines in human plasma by means of fluorescence labeling using 2-(4-hydrazinocarbonylphenyl)- 4,5-diphenylimidazole. Chem Pharm Bull (Tokyo) 1996; 44:1525-1529.
34. Minkler PE, Hoppel CL. Quantification of free carnitine, individual short- and medium-chain acylcarnitines, and total carnitine in plasma by high-performance liquid chromatography. Anal Biochem 1993; 212:510-518.
35. Longo A, Bruno G, Curti S, Mancinelli A, Miotto G. Determination of L-carnitine, acetyl-L-carnitine and propionyl-L-carnitine in human plasma by high-performance liquid chromatography after pre-column derivatization with 1-aminoanthracene. J Chromatogr 1996; 686:129-139.
36. Pace S, Longo A, Toon S, Rolan P, Evans AM. Pharmacokinetics of propionyl-L-carnitine in humans: Evidence for saturable tubular reabsorption. Br J Clin Pharmacol 2000; 50(5): 441-448.
37. Evans AM, Fornasini G. Pharmacokinetics of L-carnitine. Clin Pharmacokinet 2003 (in press).
38. Roe DS, Millington DS, Maltby DA, Bohan TP, Kahler SG, Chalmers RA. Diagnostic and therapeutic implications of medium-chain acylcarnitines in the medium-chain acyl-CoA dehydrogenase deficiency. Pediatr Res 1985; 19:459-466.
39. Lowes S, Rose ME. Simple and unambiguous method for identifying urinary acylcarnitines using gas chromatography-mass spectrometry. Analyst 1990; 115:511-516.
40. Lowes S, Rose M, Mills G, Pollitt RJ. Identification of urinary acylcarnitines using gas chromatography-mass spectrometry: Preliminary clinical applications. J Chromatogr 1992; 577:205-214.
41. Costa CG, Struys EA, Bootsma A, ten Brink HJ, Dorland L, Tavares de Almeida I, Duran M, Jakobs C. Quantitative analysis of plasma acylcarnitines using gas chromatography chemical ionization mass fragmentography. J Lipid Res 1997; 38:173-182.
42. Millington DS, Roe CR, Maltby DA. Application of high resolution fast atom bombardment and constant B/E ratio linked scanning to the identification and analysis of acylcarnitines in metabolic disease. Biomed Mass Spectrom 1984; 11:236-241.
43. Yergey AL, Liberato DJ, Millington DS. Thermospray liquid chromatography/mass spectrometry for the analysis of L-carnitine and its short-chain acyl derivatives. Anal Biochem 1984; 139:278-283.
44. Norwood DL, Kodo N, Millington DS. Application of continuous-flow liquid chromatography/fast-atom bombardment mass spectrometry to the analysis of diagnostic acylcarnitines in human urine. Rapid Commun Mass Spectrom 1988; 2:269-272.
45. Gaskell SJ, Guenat C, Millington DS, Maltby DA, Roe CR. Differentiation of isomeric acylcarnitines using tandem mass spectrometry. Anal Chem 1986; 58:2801-2805.
46. Millington DS, Kodo N, Norwood DL, Roe CR. Tandem mass spectrometry: A new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism. J Inherit Metab Dis 1990; 13:321-324.
47. Johnson AW, Mills K, Clayton PT. The use of automated electrospray ionization tandem MS for the diagnosis of inborn errors of metabolism from dried blood spots. Biochem Soc Trans 1996; 24:932-938.
48. Rashed MS, Ozand PT, Bucknall MP, Little D. Diagnosis of inborn errors of metabolism from blood spots by acylcarnitines and amino acids profiling using automated electrospray tandem mass spectrometry. Pediatr Res 1995; 38:324-331.
49. Vreken P, van Lint AEM, Bootsma AH, Overmars H, Wanders RJA, Van Gennip AH. Quantitative plasma acylcarnitine analysis using electrospray tandem mass spectrometry for the diagnosis of organic acidaemias and fatty acid oxidation defects. J Inher Metab Dis 1999; 22:302-306.
50. Wiley V, Carpenter K, Wilcken B. Newborn screening with tandem mass spectrometry: 12 months' experience in NSW Australia. Acta Paediatr Suppl 1999; 88:48-51.
51. Naylor EW, Chace DH. Automated tandem mass spectrometry for mass newborn screening for disorders in fatty acid, organic acid, and amino acid metabolism. J Child Neurol 1999; 14 Suppl 1:S4-S8.
52. Stevens RD, Hillman SL, Worthy S, Sanders D, Millington DS. Assay for free and total carnitine in human plasma using tandem mass spectrometry. Clin Chem 2000; 46:727-729.
53. Chace DH, DiPerna JC, Mitchell BL, Sgroi B, Hofman LF, Naylor EW. Electrospray tandem mass spectrometry for analysis of acylcarnitines in dried postmortem blood specimens collected at autopsy from infants with unexplained cause of death. Clin Chem 2001; 47:1166-1182.
54. Xia LJ, Folkers K. Improved methodology to assay carnidne and levels of free and total carnitine in human plasma. Biochem Biophys Res Commun 1991; 176:1617-1623.
55. Tegelaers FP, Pickkers MM, Seelen PJ. Effect of deproteinization and reagent buffer on the enzymatic assay of L-carnitine in serum. J Clin Chem Clin Biochem 1989; 27:967-972.
56. Brogan LR, Fornasini G, Chace DH, Evans AM. Evaluation of plasma L-carnitine levels in healthy individuals: Comparison of three analytical methods [Abstract]. APSA 2002 (Australasian Pharmaceutical Sciences Association) Conference in Melbourne, Victoria, Australia.
57. Evans AM, Faull R, Fornasini G, Lemanowicz EF, Longo A, Pace S, Nation RL. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis. Clin Pharmacol Ther 2000; 68:238-249.
58. Brass EP, Adler S, Sietsema KE, Hiatt WR, Orlando AM, Amato A. Intravenous L-carnitine increases plasma carnitine, redues fatigue, and may preserve exercise capacity in hemodialysis patients. Am J Kid Dis 2001; 37(5):1018-1028.
59. Rosenthal AF. Free and total serum carnitine: Shall the analyses begin? Dial Transplant 2002; 31(8):570-574.
60. Evans AM. Dialysis-related carnitine deficiency and L-carnitine pharmacology. Am J Kid Dis 2003; 41 (Suppl 4):13-26.
61. Reuter SE, Evans AM, Nation RL, Faull RJ, Prasad S, Fornasini G. Effect of chronic hemodialysis on L-carnitine and acetylcarnitine in patients with end-stage renal disease [Abstract]. APSA 2002 (Australasian Pharmaceutical Sciences Association) Conference in Melbourne, Victoria, Australia.
62. Bellinghieri G, Savica V, Mallamace A, Di Stefano C, Consolo F, Spagnoli LG, Villaschi S, Palmieri G, Corsi M, Maccari F. Correlation between increased serum and tissue L-carnitine levels and improved muscle symptoms in hemodialyzed patients. Am J Clin Nutr 1983; 38:523-531.
63. Van Es A, Ilenny F, Kooistra M, Lobatto S, Scholte HR. Amelioration of cardiac function by L-carnitine administration in patients on haemodialysis. Contrib Nephrol 1992; 98:28-35.
64. Hiatt W, Koziol B, Shapiro J, Brass E. Carnitine metabolism during exercise in patients on chronic hemodialysis. Kidney Int 1992; 41:1613-1619.
65. Giovenali P, Fenocchio D, Montanari G, Cancellotti C, D'Iddio S, Buoncristiani U, Pelagaggia M, Ribacchi R. Selective trophic effect of L-carnitine in type I and IIa skeletal muscle fibers. Kidney Int 1994; 46:1616-1619.
66. Sakurauchi Y, Matsumoto Y, Shinzato T, Takai I, Nakamura Y, Sato M, Nakai S, Miwa M, Morita H, Miwa T, et al. Effects of L-carnitine supplementation on muscular symptoms in hemodialyzed patients. Am J Kidney Dis 1998; 32:258-264.
67. Sakurabayashi T, Takaesu Y, Haginoshita S, Takeda T, Aoike I, Miyazaki S, Koda Y, Yuasa Y, Sakai S, Suzuki M, et al. Improvement of myocardial fatty acid metabolism through L-carnitine administration to chronic hemodialysis patients. Am J Nephrol 1999; 19:480-484.
68. Matsumoto Y, Sato M, Ohashi H, Araki H, Tadokoro M, Osumi Y, Ito H, Morita H, Amano I. Effects of L-carnitine supplementation on cardiac morbidity in hemodialyzed patients, Am J Nephrol 2000; 20:201-207.
69. FDA Guidance for Industry, "Bioanalytical Method Validation." May 2001.